The role of CXCL13-CXCR5 signaling in triple-negative breast cancer progression

被引：0
|
作者：
Dill, Courtney D. [1 ]
Okoro, Adaugo [1 ]
Chen, Dongquan [2 ]
Lillard, James W., Jr. [1 ]
机构：
[1] Morehouse Sch Med, Atlanta, GA 30310 USA
[2] Univ Alabama Birmingham, Birmingham, AL USA
来源：
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION | 2018年 / 27卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B50
引用
收藏
页码：134 / 134
页数：1
相关论文
共 50 条
  • [21] Pathological role of ion channels and transporters in the development and progression of triple-negative breast cancer
    Chengli Lu
    Zhiyuan Ma
    Xiaoming Cheng
    Huichao Wu
    Biguang Tuo
    Xuemei Liu
    Taolang Li
    Cancer Cell International, 20
  • [22] The role of annexin A6 in triple-negative breast cancer metabolism and disease progression
    Williams, Stephen D.
    Widatalla, Sarrah E.
    Sakwe, Amos M.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2022, 31 (01)
  • [23] The Role of Annexin A6 in Triple-negative breast cancer metabolism and disease progression
    Williams, Stephen D.
    Sakwe, Amos M.
    FASEB JOURNAL, 2022, 36
  • [24] Dipyridamole prevents triple-negative breast-cancer progression
    Spano, Daniela
    Marshall, Jean-Claude
    Marino, Natascia
    De Martino, Daniela
    Romano, Alessia
    Scoppettuolo, Maria Nunzia
    Bello, Anna Maria
    Di Dato, Valeria
    Navas, Luigi
    De Vita, Gennaro
    Medaglia, Chiara
    Steeg, Patricia S.
    Zollo, Massimo
    CLINICAL & EXPERIMENTAL METASTASIS, 2013, 30 (01) : 47 - 68
  • [25] Dipyridamole prevents triple-negative breast-cancer progression
    Daniela Spano
    Jean-Claude Marshall
    Natascia Marino
    Daniela De Martino
    Alessia Romano
    Maria Nunzia Scoppettuolo
    Anna Maria Bello
    Valeria Di Dato
    Luigi Navas
    Gennaro De Vita
    Chiara Medaglia
    Patricia S. Steeg
    Massimo Zollo
    Clinical & Experimental Metastasis, 2013, 30 : 47 - 68
  • [26] Pathological role of ion channels and transporters in the development and progression of triple-negative breast cancer
    Lu, Chengli
    Ma, Zhiyuan
    Cheng, Xiaoming
    Wu, Huichao
    Tuo, Biguang
    Liu, Xuemei
    Li, Taolang
    CANCER CELL INTERNATIONAL, 2020, 20 (01)
  • [27] Significance of LIF/LIFR Signaling in the Progression of Obesity-Driven Triple-Negative Breast Cancer
    Randolph, Lois
    Joshi, Jaitri
    Sanchez, Alondra Lee Rodriguez
    Pratap, Uday P.
    Gopalam, Rahul
    Chen, Yidong
    Lai, Zhao
    Santhamma, Bindu
    Kost, Edward R.
    Nair, Hareesh B.
    Vadlamudi, Ratna K.
    Subbarayalu, Panneerdoss
    Viswanadhapalli, Suryavathi
    CANCERS, 2024, 16 (21)
  • [28] The role of the immune system in triple-negative breast cancer
    Cvetka, Grasic Kuhar
    ONKOLOGIJA, 2020, 24 (01) : 32 - 38
  • [29] Expanding the Role for Immunotherapy in Triple-Negative Breast Cancer
    Savas, Peter
    Loi, Sherene
    CANCER CELL, 2020, 37 (05) : 623 - 624
  • [30] The Role of Immunotherapy in Triple-Negative Breast Cancer (TNBC)
    Michaels, Elena
    Chen, Nan
    Nanda, Rita
    CLINICAL BREAST CANCER, 2024, 24 (04) : 263 - 270
12345